Patents for A61K 103 - Radioactive metals (481)
08/2007
08/22/2007CN101020067A Transdermal plaster prepn for 99m TC methylene diphosphonate
08/16/2007WO2007009191A8 Method for treating cancer
08/08/2007CN1330635C Radioactive rhenium-N-accessory ingredient of alkyl dinitrogen disulfide for curing liver cancer and preparation method
08/02/2007US20070178045 Cyclopeptide derivatives with anti-integrin activity
08/01/2007EP1812115A2 Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy
08/01/2007CN101007850A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen
08/01/2007CN101007176A Drug for treating rheumatoid, rheumatic and other bone and joint diseases
07/2007
07/04/2007EP1620134B1 Microwave method for preparing radiolabelled gallium complexes
06/2007
06/27/2007CN1985997A Degradable radioactive sponge and its making process
06/20/2007EP1796738A2 Diagnostic compounds for targeting a chemokine receptor
06/20/2007EP1796737A2 Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, as well as methods of use thereof
05/2007
05/10/2007WO2007052267A2 Biodegradable composite for internal local radiotherapy
05/09/2007CN1314456C Medicament box of 2beta-[N,N'-di(2-mercaptoethyl) ethylene diamine] methyl-3 beta-(4- chlorphenyl) tropane
04/2007
04/25/2007CN1953772A Contrast medium for receptor of angiotensin ii
04/04/2007EP1768708A2 N4 chelator conjugates
04/04/2007CN1308339C 99m Tc marked polyamine complex as tumor diagnosing developing agent and its preparation
02/2007
02/28/2007EP1381397B1 Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman
02/14/2007CN1912111A Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen
01/2007
01/25/2007WO2007009191A1 Method for treating cancer
01/24/2007EP1390405B1 Preparation of cholecystokinin agonists and antagonists and their therapeutic and diagnostic use
11/2006
11/15/2006CN1861616A Compound for tumour display and caring and preparation process thereof
11/09/2006WO2006116798A1 A method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate
11/08/2006CN1283647C Technetium-99m marked isonitrile group mating material, preparing process and uses thereof
09/2006
09/21/2006WO2006072336A3 Radioactive metal complexes based on bispidine and derivatives thereof
09/13/2006EP1699494A2 Contrast agent imaging angiotensin ii receptors
08/2006
08/23/2006CN1270774C Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
08/16/2006EP1690552A2 Radiopharmaceutical kits stabilised by means of cyclodextrins
08/09/2006CN1268629C Isonitrile compound for radioactive Tc-99m label and its preparing and application
08/02/2006EP1684809A1 Chelate based scaffolds in tumor targeting
08/02/2006EP0730472B1 Immobilized labelling method
07/2006
07/27/2006WO2006008496A3 Improved n4 chelator conjugates
07/13/2006WO2006072336A2 Radioactive metal complexes based on bispidine and derivatives thereof
06/2006
06/22/2006WO2006064227A1 Magnetic resonance contrast media
06/22/2006WO2006064175A1 STABILISED 99mTC COMPOSITIONS
06/14/2006CN1786009A Application of 99TcmN (CPEDTC)2 compounding agent in tumour imaging field
06/07/2006EP1663318A1 A radioisotope-chitosan complex for treatment of prostate cancer
05/2006
05/03/2006CN1254276C Matrix metalloproteinase inhibitors as targeting components in diagnostic agents
04/2006
04/26/2006CN1762499A Medicament box of 2beta-[N,N'-di(2-mercaptoethyl) ethylene diamine] methyl-3 beta-(4- chlorphenyl) tropane
04/19/2006CN1251767C Kit for radiolabeling proteins with yttrium-90
03/2006
03/22/2006EP1635880A2 Microparticles for microarterial imaging and radiotherapy
02/2006
02/01/2006EP1620134A1 Microwave method for preparing radiolabelled gallium complexes
01/2006
01/26/2006WO2006008496A2 Improved n4 chelator conjugates
01/18/2006EP1615671A1 Microspheres comprising therapeutic and diagnostic radioactive isotopes
01/2004
01/21/2004EP1381397A2 Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman
09/2003
09/17/2003EP1091763B1 Antiviral and antiretroviral radioimmunomedicaments based on alpha-emitters and beta-emitters
05/2003
05/07/2003EP1307239A1 Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplex
03/2003
03/19/2003EP1292338A2 Stabiliser for radiopharmaceuticals
03/12/2003EP1289570A1 Liposomal encapsulation of chelated actinium-225 and uses thereof
12/2002
12/31/2002CA2044812C Radiopharmaceutical formulations, their method of administration and process of preparation
12/18/2002EP1265641A2 Imaging agents for diagnosis of parkinson's disease
04/2002
04/10/2002EP1195168A2 Ternary radiopharmaceutical complexes
04/2001
04/18/2001EP1091763A2 Antiviral and antiretroviral radioimmunomedicaments based on alpha-emitters and beta-emitters
04/18/2001EP1091757A2 Alpha emitting constructs and uses thereof
11/2000
11/02/2000EP1047457A2 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE
10/2000
10/18/2000CN1057470C Ether isonitriles and radiolabeled complexes thereof
06/2000
06/02/2000WO1999061097A9 Alpha emitting constructs and uses thereof
02/2000
02/17/2000WO2000000223A3 ANTIVIRAL AND ANTIRETROVIRAL RADIOIMMUNOMEDICAMENTS BASED ON α-EMITTERS AND β-EMITTERS
02/10/2000WO1999036105A3 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE
02/03/2000WO1999061097A3 Alpha emitting constructs and uses thereof
02/02/2000EP0975374A1 Radiometal-binding peptide analogues
01/2000
01/06/2000WO2000000223A2 ANTIVIRAL AND ANTIRETROVIRAL RADIOIMMUNOMEDICAMENTS BASED ON α-EMITTERS AND β-EMITTERS
12/1999
12/02/1999WO1999061097A2 Alpha emitting constructs and uses thereof
10/1999
10/21/1999WO1999036105A9 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE
07/1999
07/22/1999WO1999036105A2 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE
07/22/1999CA2318231A1 Use of radiolabeled monoclonal igm in therapy for cancer and autoimmune disease
09/1998
09/09/1998EP0862464A1 Amino acid analogs for tumor imaging
06/1998
06/09/1998US5762907 Frozen radiopharmaceutical formulations
10/1996
10/30/1996CN1033143C Radiopharmaceutical formulations, their method of administration and process of preparation
08/1992
08/20/1992WO1992013563A1 Antitumoral preparation and method of making same
08/19/1992CN1063615A Radiopharmaceutical formulations, their method of administration and process of preparation
07/1992
07/14/1992CA1305160C Ether isonitriles and radiolabeled complexes thereof
05/1992
05/20/1992EP0216864B1 Detection of activated platelets with antibodies to cell surface antigens
01/1992
01/08/1992CN1057585A Ether isonitriles and radiolabeled complexes thereof
12/1991
12/27/1991EP0462787A1 Radiopharmaceutical formulations, their method of administration and process of preparation
01/1991
01/29/1991US4988827 Ether isonitriles and radiolabeled complexes thereof
12/1989
12/27/1989CA1264029A1 Detection of activated platelets with antibodies to cell surface antigens
09/1989
09/26/1989EP0216864A4 Detection of activated platelets with antibodies to cell surface antigens.
04/1989
04/11/1989US4820505 Detection of activated platelets with antibodies to thrombospondin
08/1987
08/26/1987EP0233368A1 Ether isonitriles and radiolabeled complexes thereof
04/1987
04/08/1987EP0216864A1 Detection of activated platelets with antibodies to cell surface antigens.
10/1986
10/09/1986WO1986005693A1 Detection of activated platelets with antibodies to cell surface antigens
1 2 3 4 5